Although ADOA is genetically heterogeneous [11–13], the vast majority of ADOA patients (approx. 75%) harbor a mutation in the OPA1 gene, less frequent mutations in OPA3 and WFS1 are observed in ADOA patients. Here, OPA3 is linked to autosomal dominant optic atrophy.